Cardiovascular Systems, Inc.
CSII · NASDAQ
6/30/2022 | 6/30/2021 | 6/30/2020 | 6/30/2019 | |
|---|---|---|---|---|
| Market Cap | $563,339 | $1,656,185 | $1,081,406 | $1,437,678 |
| - Cash | $66,424 | $71,070 | $185,463 | $74,237 |
| + Debt | $20,298 | $20,596 | $20,818 | $20,972 |
| Enterprise Value | $517,213 | $1,605,711 | $916,761 | $1,384,413 |
| Revenue | $236,222 | $258,973 | $236,545 | $248,017 |
| % Growth | -8.8% | 9.5% | -4.6% | – |
| Gross Profit | $172,782 | $197,842 | $187,786 | $200,337 |
| % Margin | 73.1% | 76.4% | 79.4% | 80.8% |
| EBITDA | -$33,647 | -$10,218 | -$23,798 | $5,065 |
| % Margin | -14.2% | -3.9% | -10.1% | 2% |
| Net Income | -$36,933 | -$13,421 | -$27,236 | -$255 |
| % Margin | -15.6% | -5.2% | -11.5% | -0.1% |
| EPS Diluted | -0.94 | -0.35 | -0.79 | -0.008 |
| % Growth | -168.6% | 55.7% | -10,294.7% | – |
| Operating Cash Flow | -$24,272 | -$884 | -$12,765 | $10,208 |
| Capital Expenditures | -$4,220 | -$3,954 | -$4,086 | -$3,555 |
| Free Cash Flow | -$28,492 | -$4,838 | -$16,851 | $6,653 |